CopyFind
Sucotia 1000mg Oral Suspension
medicine 📍 IN

Sucotia 1000mg Oral Suspension

110,00 ₹

Analogs of Sucotia 1000mg Oral Suspension

Find cheaper analogs and generic equivalents for Sucotia 1000mg Oral Suspension.

Ingredients

सक्रिय अवयव: Sucralfate


उत्पाद अवलोकन

About Sucotia

Sucotia is a medication containing the active ingredient Sucralfate. Sucralfate, sold under various brand names, is a medication used to treat stomach ulcers, gastroesophageal reflux disease (GERD), radiation proctitis, and stomach inflammation and to prevent stress ulcers. Its usefulness in people infected by H.

Key Benefits & Uses

  • Used for: INDICATIONS AND USAGE Sucralfate tablets are indicated in: Short-term treatment (up to 8 weeks) of active duodenal ulcer
  • Used for: While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been.
  • Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Sucralfate, the active ingredient in Sucotia, is the pharmacologically active substance of this product. INDICATIONS AND USAGE Sucralfate tablets are indicated in: Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Sucotia. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Sucotia for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Sucotia 1000mg Oral Suspension.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.